NCT02581137 2026-03-18
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT05536037 2025-05-15
Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions
Thomas Jefferson University
Phase 1 Terminated
NCT03684707 2018-09-26
Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions
Ain Shams University
Phase 4 Unknown
NCT03685409 2018-09-26
Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions
Cairo University
Phase 3 Unknown